Trial Radar AI | ||
|---|---|---|
Clinical Trial NCT06213571 for FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Stage IA Uterine Corpus Cancer AJCC v8, Stage IB Uterine Corpus Cancer AJCC v8 is active, not recruiting. See the Trial Radar Card View and AI discovery tools for all the details. Or ask anything here. | ||
One trial matched filter criteria
Card View
Back to Search
Mayo ClinicRemote Home-Based Exercise Program for Strength Training in Endometrial Cancer Survivors in Rural Areas
Clinical Trial NCT06213571 is an interventional study for FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma, Stage IA Uterine Corpus Cancer AJCC v8, Stage IB Uterine Corpus Cancer AJCC v8 that is active, not recruiting. It started on 22 March 2024 with plans to enroll 80 participants. Led by Mayo Clinic, it is expected to complete by 31 March 2026. The latest data from ClinicalTrials.gov was last updated on 6 August 2025.
Brief Summary
This clinical trial studies how well a remotely delivered home-based exercise program for strength training works to positively impact endometrial cancer (EC) survivorship for patients with decreased cancer survivorship access. Cancer survivors in rural areas face barriers to supportive care, including geographic and environmental barriers to exercise and technology. Rural areas in the Midwest are underserved in terms of cancer care thus, it is essential to develop and test interventions that are scalable and can reach many individuals including those living in rural areas. Remotely-delivered exercise intervention approach allows for cancer survivors who may live far away from their primary treatment center to engage in supportive therapy via exercise interventions delivered in a sustainable context. In addition, historically black, hispanic and native endometrial cancer survivors have shorter survival and less access to survivorship care, so alternative models for healthcare delivery are needed in this underserved group. Information gained from this research may help determine whether utilizing a remotely delivered exercise program can positively impact EC survivorship for patients with decreased cancer survivorship access.
Detailed Description
PRIMARY OBJECTIVES:
I. To develop and tailor a fully remote home-based exercise intervention for EC patients.
II. To test the recruitment and retention and acceptability of a fully remote home-based telehealth exercise intervention in older adult patients that live in rural America and are survivors of early stage, low risk endometrial cancer.
III. To measure the effectiveness of exercise intervention on quality of life in endometrial cancer patients, specifically in the realm of physical functioning.
OUTLINE:
Participants participate in a home-based exercise program with an exercise prescription that will include resistance band and body weight exercises targeting the 5 major large muscle groups along with 3 booklets about exercise and exercise training and attend weekly exercise coaching sessions to report on exercise adherence and to progress exercise over 10 weeks on study.
After completion of study intervention, patients are followed up at 6 months.
Official Title
RISE: Remote Intervention for Strength Training in Endometrial Cancer
Conditions
FIGO Grade 1 Endometrial Endometrioid AdenocarcinomaFIGO Grade 2 Endometrial Endometrioid AdenocarcinomaStage IA Uterine Corpus Cancer AJCC V8Stage IB Uterine Corpus Cancer AJCC V8Other Study IDs
- 23-008883
- NCI-2023-11096 (Registry Identifier) (CTRP (Clinical Trial Reporting Program))
- 23-008883 (Other Identifier) (Mayo Clinic in Rochester)
NCT ID Number
Start Date (Actual)
2024-03-22
Last Update Posted
2025-08-06
Completion Date (Estimated)
2026-03-31
Enrollment (Estimated)
80
Study Type
Interventional
PHASE
N/A
Status
Active, not recruiting
Primary Purpose
Supportive Care
Design Allocation
N/A
Interventional Model
Single Group
Masking
None (Open Label)
Arms / Interventions
| Participant Group/Arm | Intervention/Treatment |
|---|---|
ExperimentalSupportive Care (home-based exercise program) Participants participate in a home-based exercise program with an exercise prescription that will include resistance band and body weight exercises targeting the 5 major large muscle groups along with 3 booklets about exercise and exercise training and attend weekly exercise coaching sessions to report on exercise adherence and to progress exercise over 10 weeks on study. | Exercise Counseling Participate in exercise coaching sessions Exercise Intervention Participate in home-based exercise program Health Promotion and Education Receive resistance band and exercise booklets Interview Ancillary studies Physical Performance Testing Ancillary studies Questionnaire Administration Ancillary studies Telemedicine Participate in sessions remotely |
Primary Outcome Measures
Secondary Outcome Measures
| Outcome Measure | Measure Description | Time Frame |
|---|---|---|
Retention of participants | Assessed by the number of patients who complete 75% or more of the twice weekly exercise program. | Up to 2 years |
Satisfaction with program - self-reported | Assessed by a simple participant satisfaction survey after completion of the 10-week exercise intervention. Qualitative interviews will be performed at the completion of the program regardless of level of participation to assess facilitators, barriers, and motivators to participation. | 10 weeks |
Feasibility of intervention | Technological questions and problems that arise during the exercise intervention will be recorded to assess the ability to fully perform telehealth exercise interventions in a rural cancer population | Up to 2 years |
| Outcome Measure | Measure Description | Time Frame |
|---|---|---|
Change in physical function | Assessed using the Patient-Reported Outcomes Measurement Information System (PROMIS) Physical Function Short Form 6b assessment, a 6-item questionnaire answered on a scale from 5 (Without any difficulty or Not at all) to 0 (Unable to do or Cannot do). | Baseline; 10 weeks (end of exercise intervention); 6 months after completion of intervention |
Eligibility Criteria
Eligible Ages
Adult, Older Adult
Minimum Age
50 Years
Eligible Sexes
Female
- Age 50+
- Stage IA-IB endometrial cancer
- Grade 1-2 disease
- No recurrence documented
- Internet access
- Access to a remote device with a camera such as a computer, smartphone or tablet
- > 1 year but less than 5 years from surgery
- Primary residence in rural-urban commuting area (RUCA) (rural-urban commuting area) codes 4.0 through 10.0 or of American Indian, Alaskan Native, Black or Hispanic background
- Paraplegia/hemiplegia
- No English speaking
Mayo Clinic868 active trials to exploreNo contact data.
1 Study Locations in 1 Countries
Minnesota
Mayo Clinic in Rochester, Rochester, Minnesota, 55905, United States